Cases & Deals

Cougar Biotech gets purchased by J & J, including global patent portfolio for prostate cancer treatment

Client(s) Cougar Biotechnology, Inc.

Jones Day assisted Cougar Biotechnology in the management and prosecution of a worldwide patent portfolio for the phase III clinical candidate, abiraterone acetate, which is being developed for use in the treatment of prostate cancer and which resulted in the sale of Cougar to Johnson & Johnson for $970 million.